|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: VIROPHARMA INC, 10-Q, EX-10.1, 2000-08-07 |
Next: AVIRON, 424B2, 2000-08-07 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C> <C>
<PERIOD-TYPE> 3-MOS 6-MOS
<FISCAL-YEAR-END> DEC-31-2000 DEC-31-2000
<PERIOD-START> APR-01-2000 JAN-01-2000
<PERIOD-END> JUN-30-2000 JUN-30-2000
<CASH> 2,088,016 2,088,016
<SECURITIES> 223,630,647 223,630,647
<RECEIVABLES> 4,733,814 4,733,814
<ALLOWANCES> 0 0
<INVENTORY> 0 0
<CURRENT-ASSETS> 230,636,118 230,636,118
<PP&E> 5,811,817 5,811,817
<DEPRECIATION> 1,616,051 1,616,051
<TOTAL-ASSETS> 240,887,714 240,887,714
<CURRENT-LIABILITIES> 10,176,202 10,176,202
<BONDS> 0 0
0 0
2,300 2,300
<COMMON> 30,371 30,371
<OTHER-SE> 46,753,841 46,753,841
<TOTAL-LIABILITY-AND-EQUITY> 240,887,714 240,887,714
<SALES> 0 0
<TOTAL-REVENUES> 250,000 1,500,000
<CGS> 0 0
<TOTAL-COSTS> 0 0
<OTHER-EXPENSES> 6,320,338 15,001,204
<LOSS-PROVISION> 0 0
<INTEREST-EXPENSE> 2,734,757 3,670,468
<INCOME-PRETAX> (5,389,244) (12,159,172)
<INCOME-TAX> 0 0
<INCOME-CONTINUING> (5,389,244) (12,159,172)
<DISCONTINUED> 0 0
<EXTRAORDINARY> 0 0
<CHANGES> 0 0
<NET-INCOME> (5,389,244) (12,159,172)
<EPS-BASIC> (0.37) (0.83)
<EPS-DILUTED> (0.37) (0.83)
</TABLE>
|
|